Differential regulation of alternate UDP-glucuronosyltransferase 1A6 gene promoters by hepatic nuclear factor-1

被引:19
|
作者
Auyeung, DJ [1 ]
Kessler, FK [1 ]
Ritter, JK [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
UDP-glucuronosyltransferase; gene regulation; alternative promoter; hepatic nuclear factor;
D O I
10.1016/S0041-008X(03)00230-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferase 1A6 (UGT1A6) is a major UGT contributing to the glucuronidation of small phenolic compounds. The gene for rat 1A6 is expressed using two promoters, a distal promoter P I and a proximal promoter P2. Transcripts from P2 are high in liver, gastrointestinal tract, and kidney, whereas PI transcripts predominate in other tissues. Here we report evidence for primary control of the P2 promoter by hepatic nuclear factor I (HNF1). Transient transfection of a P2 reporter plasmid, p(-1354/+65) 1A6P2-luc, resulted in enhanced luciferase activity in HepG2 but not Hepa1 cells compared to cells transfected with pGL3-Basic control vector. A truncated reporter under the control of -224 to +65 exhibited comparable activity. Footprint analysis of the -224/+65 fragment revealed specific binding by rat liver nuclear protein to a region between bases -60 and -37. The binding activity was also observed with HepG2 cell but not Hepa1 cell extract. Electrophoretic mobility shift assays were consistent with the presence of HNF1 in the binding complexes. The functionality of an HNF1-binding site at -51/-37 is also supported by (1) marked decreases in the activity of P2 reporter plasmids containing a three-base substitution in the proposed HNF1 binding site and (2) the enhancement of P2 reporter activity following cotransfection of an HNF1alpha expression plasmid. The UGT1A6 P1 promoter lacks an HNF1 binding site in the analogous position and showed little response to HNF1 overexpression. Although these data do not strictly rule out an interaction between the PI promoter and HNF1 bound to -51/-37 of P2, the results suggest a mechanism for the more abundant expression of P2-derived UGT1A6 transcripts in liver and other HNF1-enriched tissues. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:156 / 166
页数:11
相关论文
共 50 条
  • [21] Co-regulation of hepatic UDP-glucuronosyltransferase 1 as by transcription factors.
    Ramirez, J.
    Liu, W.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S80 - S80
  • [22] Interaction of periodate-oxidized UDP-glucuronic acid with recombinant human liver UDP-glucuronosyltransferase 1A6
    Battaglia, E
    Terrier, N
    Mizeracka, M
    Senay, C
    Magdalou, J
    Fournel-Gigleux, S
    Radominska-Pandya, A
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (08) : 812 - 817
  • [23] Isolation of the UDP-glucuronosyltransferase 1A3 and 1A4 proximal promoters and characterization of their dependence on the transcription factor hepatocyte nuclear factor 1α
    Gardner-Stephen, Dione A.
    Mackenzie, Peter I.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (01) : 116 - 120
  • [24] An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplasmic reticulum
    Ouzzine, M
    Magdalou, J
    Burchell, B
    Fournel-Gigleux, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (44) : 31401 - 31409
  • [25] UDP-glucuronosyltransferase 1A6 is the major isozyme responsible for protocatechuic aldehyde glucuronidation in human liver microsomes
    Liu, Hui-Xin
    Liu, Yong
    Zhang, Jiang-Wei
    Li, Wei
    Liu, Hong-Tao
    Yang, Ling
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (08) : 1562 - 1569
  • [26] Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in β-thalassemia/HbE
    Tankanitlert, Jeeranut
    Morales, Noppawan Phumala
    Howard, Thad A.
    Fucharoen, Pranee
    Ware, Russell E.
    Fucharoen, Suthat
    Chantharaksri, Udom
    PHARMACOLOGY, 2007, 79 (02) : 97 - 103
  • [27] N-glycosylation affected the expression, activity, and cellular functions of human UDP-glucuronosyltransferase 1A6 (UGT1A6)
    Liu, Yuejian
    Coughtrie, Michael W. H.
    Collier, Abby C.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2021, 99 (11) : S7 - S7
  • [28] Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6
    Krishnaswamy, S
    Duan, SX
    Von Moltke, LL
    Greenblatt, DJ
    Court, MH
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) : 133 - 139
  • [29] Effect of Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 (UGT1A6) on Acetylsalicylic Acid Metabolism in Healthy Female Volunteers
    van Oijen, Martijn G. H.
    Barthelemy, Christine
    Janssen, Marcel J. R.
    Joiris, Etienne
    Peters, Wilbert H. M.
    Laheij, Robert J. F.
    Smits, Paul
    Odou, Pascal
    Jansen, Jan B. M. J.
    PHARMACOLOGY, 2009, 83 (04) : 237 - 242
  • [30] Regulation via nuclear receptor of the human UDP-glucuronosyltransferase (UGT) 1a3
    Erichsen, T. J.
    Lankisch, T. O.
    Ehmer, U.
    Gillman, T. C.
    Remmel, R. P.
    Manns, M. P.
    Strassburg, C. P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S149 - S149